Monthly Archives: September 2021
Out of with the old, in with the new: Replacing the “6-month abstinence rule” with Integrated Care for Alcohol-Associated Liver Disease.
Posted in News
Comments Off on Out of with the old, in with the new: Replacing the “6-month abstinence rule” with Integrated Care for Alcohol-Associated Liver Disease.
Correction
Pariente B, Torres J, Burisch J, et al. Validation and Update of the Lémann Index to Measure Cumulative Structural Bowel Damage in Crohn’s Disease. Gastroenterology 2021;161:853–864. Continue reading
Posted in News
Comments Off on Correction
Correction
Pariente B, Torres J, Burisch J, et al. Validation and Update of the Lémann Index to Measure Cumulative Structural Bowel Damage in Crohn’s Disease. Gastroenterology 2021;161:853–864. Continue reading
Posted in News
Comments Off on Correction
Correction
Jammula S, Katz-Summercorn AC, Li X, et al. Identification of Subtypes of Barrett’s Esophagus and Esophageal Adenocarcinoma Based on DNA Methylation Profiles and Integration of Transcriptome and Genome Data. Gastroenterology 2020;158:1682–1697. Continue reading
Posted in News
Comments Off on Correction
Correction
Kobayashi H, Gieniec KA, Wright JA, et al. The Balance of Stromal BMP Signaling Mediated by GREM1 and ISLR Drives Colorectal Carcinogenesis. Gastroenterology 2021;160:1224–1239. Continue reading
Posted in News
Comments Off on Correction
Chemoradiotherapy for T1bN0M0 esophageal squamous cell carcinoma: a practical dilemma delimited by invasion depth
Posted in News
Comments Off on Chemoradiotherapy for T1bN0M0 esophageal squamous cell carcinoma: a practical dilemma delimited by invasion depth
Inclusion of Under-Represented Racial and Ethnic Minorities in Randomized Clinical Trials for Inflammatory Bowel Disease
Posted in News
Comments Off on Inclusion of Under-Represented Racial and Ethnic Minorities in Randomized Clinical Trials for Inflammatory Bowel Disease
Correction
Xie J-J, Jiang Y-Y, Jiang Y, et al. Super-Enhancer-Driven Long Non-Coding RNA LINC01503, Regulated by TP63, Is Over-Expressed and Oncogenic in Squamous Cell Carcinoma. Gastroenterology 2018;154:2137–2151. Continue reading
Posted in News
Comments Off on Correction
Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver Disease
Find AGA’s NASH Clinical Care Pathway App for iOS and Android mobile devices at nash.gastro.org. Scan this QR code to be taken directly to the website.Nonalcoholic fatty liver disease (NAFLD) is becoming increasingly common, currently affecting approxi… Continue reading
Posted in News
Comments Off on Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver Disease
How to approach long-term enteral and parenteral nutrition
Posted in News
Comments Off on How to approach long-term enteral and parenteral nutrition